BCL7A and acute myeloid leukemia: We observed a significant negative correlation between BCL7A promoter methylation and BCL7A mRNA expression in three independent AML patient cohorts (Fig. 1a), suggesting that differential methylation of the BCL7A promoter may affect BCL7A mRNA expression in AML.